BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35510500)

  • 1. Distribution of
    Garrigos T; Dollat M; Magallon A; Folletet A; Bador J; Abid M; Amara M; Beauruelle C; Belmonte O; Boyer P; Cardot-Martin E; Cauchie AG; Colin de Verdière S; Daurel C; Gaudru C; Hamdad F; Héry-Arnaud G; Hoellinger B; Lamoureux C; Lartigue MF; Malandain D; Marchand O; Piau C; Picot S; Revillet H; Sabouni Z; Neuwirth C; Amoureux L
    J Clin Microbiol; 2022 Jun; 60(6):e0242221. PubMed ID: 35510500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients.
    Garrigos T; Dollat M; Magallon A; Chapuis A; Varin V; Bador J; Makki N; Cremet L; Persyn E; Cardot-Martin E; Echahidi F; Peeters C; Pierard D; Vandamme P; Verroken A; Neuwirth C; Amoureux L
    J Clin Microbiol; 2021 Sep; 59(10):e0094621. PubMed ID: 34346714
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS).
    Garrigos T; Neuwirth C; Chapuis A; Bador J; Amoureux L;
    Clin Microbiol Infect; 2021 Jan; 27(1):126.e1-126.e5. PubMed ID: 32283265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Rodrigues ER; Ferreira AG; Leão RS; Leite CC; Carvalho-Assef AP; Albano RM; Marques EA
    J Clin Microbiol; 2015 Dec; 53(12):3894-6. PubMed ID: 26400790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exoproducts of the Most Common
    Sahl C; Baumgarten M; Shannon O; Påhlman LI
    Microbiol Spectr; 2023 Aug; 11(4):e0019523. PubMed ID: 37284754
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission and Antibiotic Resistance of
    Gabrielaite M; Bartell JA; Nørskov-Lauritsen N; Pressler T; Nielsen FC; Johansen HK; Marvig RL
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33472899
    [No Abstract]   [Full Text] [Related]  

  • 9. Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina.
    Papalia M; Steffanowski C; Traglia G; Almuzara M; Martina P; Galanternik L; Vay C; Gutkind G; Ramírez MS; Radice M
    Rev Argent Microbiol; 2020; 52(1):13-18. PubMed ID: 31253503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.
    Degand N; Carbonnelle E; Dauphin B; Beretti JL; Le Bourgeois M; Sermet-Gaudelus I; Segonds C; Berche P; Nassif X; Ferroni A
    J Clin Microbiol; 2008 Oct; 46(10):3361-7. PubMed ID: 18685005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALDI-TOF: a useful tool for laboratory identification of uncommon glucose non-fermenting Gram-negative bacteria associated with cystic fibrosis.
    Homem de Mello de Souza HAP; Dalla-Costa LM; Vicenzi FJ; Camargo de Souza D; Riedi CA; Filho NAR; Pilonetto M
    J Med Microbiol; 2014 Sep; 63(Pt 9):1148-1153. PubMed ID: 24980571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137.
    Amoureux L; Sauge J; Sarret B; Lhoumeau M; Bajard A; Tetu J; Bador J; Neuwirth C;
    J Cyst Fibros; 2019 Nov; 18(6):804-807. PubMed ID: 31104975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 14. Genotypic and phenotypic applications for the differentiation and species-level identification of achromobacter for clinical diagnoses.
    Gomila M; Prince-Manzano C; Svensson-Stadler L; Busquets A; Erhard M; Martínez DL; Lalucat J; Moore ER
    PLoS One; 2014; 9(12):e114356. PubMed ID: 25474264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.
    Filipic B; Malesevic M; Vasiljevic Z; Lukic J; Novovic K; Kojic M; Jovcic B
    Front Cell Infect Microbiol; 2017; 7():224. PubMed ID: 28611955
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and distribution of Achromobacter species in cystic fibrosis.
    Spilker T; Vandamme P; Lipuma JJ
    J Cyst Fibros; 2013 May; 12(3):298-301. PubMed ID: 23141756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.
    Ridderberg W; Wang M; Nørskov-Lauritsen N
    J Clin Microbiol; 2012 Aug; 50(8):2688-94. PubMed ID: 22675125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and variability of siderophore production in the
    Sorlin P; Brivet E; Jean-Pierre V; Aujoulat F; Besse A; Dupont C; Chiron R; Jumas-Bilak E; Menetrey Q; Marchandin H
    Microbiol Spectr; 2024 Mar; 12(3):e0295323. PubMed ID: 38315029
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients.
    Marko DC; Saffert RT; Cunningham SA; Hyman J; Walsh J; Arbefeville S; Howard W; Pruessner J; Safwat N; Cockerill FR; Bossler AD; Patel R; Richter SS
    J Clin Microbiol; 2012 Jun; 50(6):2034-9. PubMed ID: 22495566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.
    Pereira RH; Leão RS; Carvalho-Assef AP; Albano RM; Rodrigues ER; Firmida MC; Folescu TW; Plotkowski MC; Bernardo VG; Marques EA
    Epidemiol Infect; 2017 Feb; 145(3):600-606. PubMed ID: 27873565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.